These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10965597)

  • 1. Diazabicyclo[3.3.1]nonanone-type ligands for the opioid receptors.
    Kuhl U; Englberger W; Haurand M; Holzgrabe U
    Arch Pharm (Weinheim); 2000 Jul; 333(7):226-30. PubMed ID: 10965597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and opioid receptor affinity of bivalent ligands derived from 3,8-diazabicyclo(3.2.1)octanes.
    Barlocco D; Fadda P; Fratta W
    Farmaco; 1993 Mar; 48(3):387-96. PubMed ID: 8391821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, modelling, and mu-opioid receptor affinity of N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicycl.
    Pinna GA; Murineddu G; Curzu MM; Villa S; Vianello P; Borea PA; Gessi S; Toma L; Colombo D; Cignarella G
    Farmaco; 2000 Aug; 55(8):553-62. PubMed ID: 11132733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and opioid receptor affinity of a series of 2, 4-diaryl-substituted 3,7-diazabicylononanones.
    Siener T; Cambareri A; Kuhl U; Englberger W; Haurand M; Kögel B; Holzgrabe U
    J Med Chem; 2000 Oct; 43(20):3746-51. PubMed ID: 11020289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivatives.
    Barlocco D; Cignarella G; Vianello P; Villa S; Pinna GA; Fadda P; Fratta W
    Farmaco; 1998; 53(8-9):557-62. PubMed ID: 10081818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].
    Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ
    J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors.
    Loriga G; Manca I; Murineddu G; Chelucci G; Villa S; Gessi S; Toma L; Cignarella G; Pinna GA
    Bioorg Med Chem; 2006 Feb; 14(3):676-91. PubMed ID: 16243530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for the pharmacophore in kappa-agonistic diazabicyclo[3.3.1]nonan-9-one-1,5-diesters and arylacetamides.
    Brandt W; Drosihn S; Haurand M; Holzgrabe U; Nachtsheim C
    Arch Pharm (Weinheim); 1996 Jun; 329(6):311-23. PubMed ID: 8767114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzofuro[2,3-c]pyridin-6-ols: synthesis, affinity for opioid-receptor subtypes, and antinociceptive activity.
    Hutchison AJ; de Jesus R; Williams M; Simke JP; Neale RF; Jackson RH; Ambrose F; Barbaz BJ; Sills MA
    J Med Chem; 1989 Sep; 32(9):2221-6. PubMed ID: 2549247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of novel opioid ligands with an azabicyclo[2.2.2]octane skeleton and their pharmacologies.
    Watanabe Y; Kitazawa S; Fujii H; Nemoto T; Hirayama S; Nagase H
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2689-92. PubMed ID: 22445285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent and long-lasting ligand, azabicyclononane (P-7521).
    Chi ZQ; Jin WQ
    Prog Clin Biol Res; 1990; 328():1-4. PubMed ID: 2154758
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of 3,8-diazabicyclo (3.2.1) octanes with mu and delta opioid receptors.
    Cignarella G; Barlocco D; Tranquillini ME; Volterra A; Brunello N; Racagni G
    Pharmacol Res Commun; 1988 May; 20(5):383-94. PubMed ID: 2843931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinans.
    Ananthan S; Khare NK; Saini SK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem; 2003 Sep; 11(18):4143-54. PubMed ID: 12927876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines.
    Hsin LW; Chang LT; Rothman RB; Dersch CM; Fishback JA; Matsumoto RR
    J Med Chem; 2010 Feb; 53(3):1392-6. PubMed ID: 20055417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characterization of 9 slowly dissociated opioid ligands azabicyclononances compounds to mu, delta, and kappa receptors].
    Fan LQ; Jin WQ; Chi ZQ
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):245-9. PubMed ID: 1664168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frog venom cocktail yields a one-handed painkiller.
    Bradley D
    Science; 1993 Aug; 261(5125):1117. PubMed ID: 8356446
    [No Abstract]   [Full Text] [Related]  

  • 20. 10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.
    Zhang A; Xiong W; Bidlack JM; Hilbert JE; Knapp BI; Wentland MP; Neumeyer JL
    J Med Chem; 2004 Jan; 47(1):165-74. PubMed ID: 14695830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.